<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:department>Human Genetics</gtr:department><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/778FA33A-00E3-4FC8-ACEF-68814849AAF8"><gtr:id>778FA33A-00E3-4FC8-ACEF-68814849AAF8</gtr:id><gtr:firstName>Lee</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Turnpenny</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G113%2F10"><gtr:id>A98E8EF2-47DD-49BD-82D8-687F031C8C2F</gtr:id><gtr:title>Derivation and self-renewal of human pluripotent stem cells - the investigation of human embryonic germ cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G113/10</gtr:grantReference><gtr:abstractText>During human development, a small group of cells in the early embryo differentiate, giving rise to all the tissues and organs of the body. This capacity for differentiation is retained by the embryo?s primordial germ cells, from which sperm or eggs ultimately arise. Remarkably, when these two embryonic cell types are isolated in the laboratory, they can acquire another important property - that of indefinite self-renewal in their undifferentiated state. Called embryonic stem (ES) and embryonic germ (EG) cells, respectively, they are termed ?pluripotent?, because they retain the potential to differentiate into any cell type. Ethical regulations govern access to human embryonic cells. However, scientists believe they can be used to generate different cells for curing many important debilitating diseases, including diabetes, Parkinson?s disease and cancer. Research with hEG cell derivatives has demonstrated their potential and safety for transplantation therapies and advocates for EG cell inclusion in stem cell research. Pivotal, however, is the ability to grow these pluripotent cells in sufficient quantities in the laboratory. Therefore, drawing on training collaborations with renowned experts, this fellowship will investigate: (i) the factors that influence hEG cell derivation and; (ii) the pathways necessary for the maintenance of hEG cell pluripotency based on derivation and cell-signalling studies in mouse ES and EG cells.</gtr:abstractText><gtr:technicalSummary>Human embryonic germ (hEG) cells are a source of pluripotent stem cells that draw scant attention in the field of stem cell research. Nevertheless, recent therapeutic and epigenetic studies have demonstrated the potential application and safety of hEG derivatives as transplantable treatment for degenerative diseases. These findings advocate strongly for the inclusion of hEG cells, alongside human embryonic stem (hES) cells, in research programs. Nevertheless, substantial hurdles remain: before the differentiation of human stem cells for therapeutic value, adequate numbers of pluripotent cells need to be derived and expanded. Pivotal to this progress is an increased understanding of the factors and signalling pathways critical to their derivation and maintenance of pluripotency.
Despite characteristics shared with mouse and human ES cells, conflicting observations suggest factors intrinsic and/or extrinsic to hEG cells affect their properties, such as: efficiency of derivation, spontaneous differentiation, and the responsiveness to - and requirement for - various signalling factors. These issues require resolution. Therefore, drawing on training collaborations with renowned experts, this fellowship seeks to determine and investigate: (i) the factors that influence hEG cell derivation and; (ii) the pathways necessary for the maintenance of hEG cell pluripotency.
Based at Southampton, I am continuing to derive hEG cells from PGCs, and will determine the presence of the component factors of signalling pathways in PGCs and hEG cells. This will provide the base knowledge, upon which to conduct experiments to ascertain those pathways involved in hEG cell derivation. These studies will be progressed at Johns Hopkins University, Baltimore, where, under the guidance of Dr. Peter Donovan, I will gain experience with the mouse modal for cross-comparison with hEG cell derivation. Subsequently, I will progress to a detailed investigation of the transcription factors active in the maintenance of hEG cell self-renewal and pluripotency, via training in Edinburgh with Austin Smith, who has dissected the functioning of such factors in ES cells.
The collaborative periods proposed in this fellowship will benefit my return to Southampton, where I will be able to apply my training in first-class dedicated stem cell laboratories in a new Developmental Origins of Health &amp;amp; Disease building. Integrating with other group researchers, findings from these studies will carry significant comparative implications for hES cells. This application is timely, both for the progression of stem cell biology, and to promote my transition to independent researcher, as part of a cohesive Southampton Stem Cell and Embryo Group.</gtr:technicalSummary><gtr:fund><gtr:end>2009-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>163709</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>0A4B3D00-B293-47C2-9FED-2C2FCE61B19D</gtr:id><gtr:impact>International Society for Stem Cell Research (ISSCR) conference June 2007, Cairns, Australia. O=Poster title: 'Religious attitudes to human embryonic stem cell research and 'cloning'.'

No subsequent impact</gtr:impact><gtr:outcomeId>2AE04BC535A</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Journal correspondence</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>4569B7D7-83C7-4447-BBAF-CC15E7BD13B9</gtr:id><gtr:impact>Is 'cloning' mad, bad and dangerous? EMBO Rep. 2007 Jan;8(1):2. PMID: 17203093

No subsequent impact</gtr:impact><gtr:outcomeId>BA0BB966FA1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>766B074F-A83F-41E0-B540-DCD0C9F91F5D</gtr:id><gtr:impact>'Journal Club: A stem-cell researcher considers an accusation of dullness.' Nature 459: 143.

No subsequent impact</gtr:impact><gtr:outcomeId>07C52951618</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>31029012-9B93-4EFA-BBEC-7E0D6FEAD23F</gtr:id><gtr:impact>'Real support for early-career biologists: give them a job!' Biologist 55 (4): 228-229.

No subsequent impact</gtr:impact><gtr:outcomeId>126E66F3951</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Article</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>71C5EC7B-D035-47D2-A8F0-61E31F035B2E</gtr:id><gtr:impact>Turnpenny L &amp;amp; Carroll M. 'Do your homework! An open letter to science teachers.' Science &amp;amp; Public Affairs (the BA) June: 28.

No subsequent impact</gtr:impact><gtr:outcomeId>52BBA6E322F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Book chapter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>3A8CF22A-7D93-4483-8C8C-AE11CE19B143</gtr:id><gtr:impact>'Culture of the Human Germ Cell Lineage.' In 'Culture of Human Stem Cells' ; (Eds. Freshney, R.I., Stacey, G.N., Auerbach, J.M.): 107-132 (Wiley &amp;amp; Sons, NJ, USA).

No subsequent impact</gtr:impact><gtr:outcomeId>6B691AAD159</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Journal correspondence</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>5E7FDF88-C8EC-4064-8903-FAA08B4C7F6B</gtr:id><gtr:impact>What ID is, beyond what it is not. Nat Methods. 2008 Feb;5(2):117. PMID: 18235429

No subsequent impact</gtr:impact><gtr:outcomeId>70FA00BC1F0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>30D572AE-AEAF-438A-A15C-9C166FFF4334</gtr:id><gtr:title>Evaluating human embryonic germ cells: concord and conflict as pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19d530596127b5f9327d7884fd62393d"><gtr:id>19d530596127b5f9327d7884fd62393d</gtr:id><gtr:otherNames>Turnpenny L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>2D85FEE1E41</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89458FF0-22FB-4BE4-A37C-6736F5A598D4</gtr:id><gtr:title>Human embryonic germ cells for future neuronal replacement therapy.</gtr:title><gtr:parentPublicationTitle>Brain research bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19d530596127b5f9327d7884fd62393d"><gtr:id>19d530596127b5f9327d7884fd62393d</gtr:id><gtr:otherNames>Turnpenny L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0361-9230</gtr:issn><gtr:outcomeId>C50A9F051F2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A8818A8-FA08-4491-91F2-2D467D68EFCD</gtr:id><gtr:title>The early human germ cell lineage does not express SOX2 during in vivo development or upon in vitro culture.</gtr:title><gtr:parentPublicationTitle>Biology of reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b007f5d40ea3ff605fc80678bc546efc"><gtr:id>b007f5d40ea3ff605fc80678bc546efc</gtr:id><gtr:otherNames>Perrett RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3363</gtr:issn><gtr:outcomeId>8BB3EDCEEC3</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G113/10</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>